Choroidal Neovascularization Market
Choroidal Neovascularization Market Research Report By Treatment Type (Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium), By Indication (Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications), By Route of Administration (Intravitreal, Subconjunctival, Periocular, Oral), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Global Choroidal Neovascularization Market Overview
As per MRFR analysis, the Choroidal Neovascularization Market Size was estimated at 1.58 (USD Billion) in 2022.
The Choroidal Neovascularization Market is expected to grow from 1.68 (USD Billion..